Cancer Home > Neulasta Dosage

The recommended Neulasta dosage for the prevention of infections in people undergoing chemotherapy is 6 mg injected once per chemotherapy cycle. This suggested dose is the same for all adults, regardless of age or kidney or liver function. You should not take your Neulasta dose any time within two weeks before until 24 hours after chemotherapy.

Neulasta Dosage: An Introduction

There is only one recommended dose of Neulasta® (pegfilgrastim) for adults, regardless of your age, liver function, or kidney function. As is always the case, do not adjust your Neulasta dose unless your healthcare provider specifically instructs you to do so.

Neulasta Dosing for Preventing Infections

The recommended Neulasta dose for preventing infections due to chemotherapy is 6 mg injected just under the skin once per chemotherapy cycle. Neulasta should not be given any time within two weeks before chemotherapy until 24 hours after chemotherapy. It is usually given on the day after chemotherapy (more than 24 hours afterwards).
Neulasta comes only in the 6 mg dosage, which is too high for children and adolescents weighing less than 99 pounds.

General Neulasta Dosage Information

Considerations for people taking Neulasta include the following:
  • Neulasta comes as an injection that is given under the skin. It is given once per chemotherapy cycle.
  • If you feel comfortable doing so, you may give yourself Neulasta injections. If you would prefer, your healthcare provider can give the injection.
  • Never shake Neulasta, as it is a delicate molecule that could be damaged by shaking.
  • You will need regular blood tests while taking Neulasta to see if the drug is working.
  • If you choose to give the injections yourself, make sure you know exactly how to inject Neulasta.
  • For the medication to work properly, it must be taken as prescribed.
  • If you are unsure about anything related to Neulasta or your Neulasta dosage, talk to your doctor, nurse, or pharmacist. Do not stop taking the drug without discussing it with your healthcare provider.
Written by/reviewed by:
Last reviewed by: Kristi Monson, PharmD;
Last updated/reviewed:
List of references (click here):
Other Articles in This eMedTV Presentation




Related Channels

eMedTV Links
Copyright © 2006-2020 Clinaero, Inc.

eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.

This site complies with the HONcode standard for trustworthy health information:
verify here.